Wearable Drug Delivery
These are changing the world of drug delivery and preventing the patients from continuous bulk ambulatory devices. Wearable drug delivery device delivers insulin to the wearer. These are developed for dosing a range of drugs such as hormones, analgesics, anti-hypertensives. Large doses 5ml to 50 ml can be comfortably be self-administered by the patient at home by using the Wearable Drug Delivery devices. The life cycle of the product can also be increases. Wearable technology speeds the Formulation and development.
The annual growth rate is expected to reach USD $824 bn by 2025. The size of the market opportunity for LVI devices alone has been estimated at $8.1 billion by 2025, with over 50% of this driven by devices to deliver drugs for cancer and related conditions.
- Perspectives on Wearable Drug Delivery
- Wearable Drug Delivery System
- Wearable smart dose injectors
- Design and Operational Challenges of Wearable Drug Delivery Systems
Related Conference of Wearable Drug Delivery
Wearable Drug Delivery Conference Speakers
Recommended Sessions
- Bioavailability and Bioequivalence Studies
- Challenges in Drug Administration
- Drug Delivery approaches for Parenterals
- Drug Delivery Devices: Approaches and Manufacturing
- Drug Delivery Technologies
- Drug Designing and Development
- Entrepreneurs Investment Meet
- Novel Drug Delivery Systems
- Novel Drug Formulation Procedures
- Pharmaceutical Analysis Methods
- Pharmaceutical Excipients Development
- Pharmaceutical Formulations: Academic and Industry Perspective
- Pharmaceutical Formulations: Types and Novelties
- Pharmaceutical IPR and Regulatory Affairs
- Pharmaceutical Nanotechnology: Challenges and Opportunities
- Pharmaceutical Research and Development
- Transdermal & Intradermal Drug Delivery Systems
- Wearable Drug Delivery